Misoprostol, sold under the brand name Cytotec among others, is a medication used to prevent and treat stomach ulcers, start labor, cause an abortion, and treat postpartum bleeding due to poor contraction of the uterus. For abortions it is often used with mifepristone or methotrexate abortion pill online home abortion medical abortion pregnancy termination pills dubai. mifepristone 200mcg safe abortion pills in dubai. where I get abortion pills dubai
to help him those people who was living in dubai/uae and make unsafe sexual relation both each other. band women become pregnant and worry about his her unwanted pregnancy .she is not ready and not Offord unwanted pregnancy so she is want to abort and terminated his pregnancy 1 up to 12 weeks when she is alone at home .want to get 100% result without any risk and perforce buy online and easily abortion pills in Dubai to make medical abortion procedure at home secretly at Dubai pregnancy clinic
The story of a woman
I want to tell the story of an incident that happened to me and it is based on fact and truth. I am from Russia for paying her my job duties in untied Arab emirates(Uae) . I live in Dubai in the UAE during his job I get a friend belong from India after some days later they build relation .sexual relation automatically build its a natural thinks and there are routines in the office. Become friends with a boy
Gradually, the friendship turned into a close relationship, and the two became very close together. This took us to the last point and the physical relationship began to form between us. Everything was gone. I had a lot of fun with this physical relationship but was unaware of the result. The physical relationship had become a daily routine. It was such a life that I suddenly stopped being menstruating.
I was very upset because I was not married to my boyfriend. Because Dubai is a Muslim country where abortion is not readily available. I was worried about having a medical test. That I was pregnant for 3 weeks because I was not in a position to have a baby and I decided to have an abortion. Abortion is not possible for people there. I was very upset about this. My boyfriend was also suddenly heard about my attack. He was afraid forb this .
if I living in Russia there is abortion was not difficulty. but I am not going back to home because some job issue facing in dubai .so I was share my problem to my close friend who was living in Canada. She advice to me try to search on google with the some title words like "" Abortion Pills available in dubai"" Abortion pills in dubai""
after that am searching on google in dubai site .Then I saw the more webs site and cell number available in google site mostly the person are fake on google site but one of the Best lady with real website was named (abortion pills available in dubai 00971 56 2013046) was got it she is perfectly guide to us .she is not fake site its a 100% original .
I am get great help when I told his problem she guide me properly and shopped me abortion pills in dubai at my door step
she is also contact at text WhatsApp (00971 56 2013046) .
now a day I am leave happily and my life is going on .......so for
its my advice if a women worry about his her unwanted pregnancy and living in dubai abu dhabi sharjah ajman Al ain ras al khaimah fujairah and other side of the state of Uae .you make sure to make a one call And WhatsApp message on her mobile number (00971 56 2013046) she must help you .
she is real lady on google .who was selling original abortion pills in dubai with title name of
1. abortion pills available in dubai
2. abortion pill in dubai
3 abortion pills for sale in dubai
4 morning after pills in dubai
5 I pill in dubai
6 birth control pills available in dubai
7 abortion pills sale in Uae
8 abortion pills available in abu dhabi
10 abortion pills available in sharjah
11 abortion pills available in fujairah
every male and female human make naturally sex relation in world.
male and female become in marriage relation .or not marriage make but if build sexual relation women and men both with mutual understanding .
after his relaxation women become a pregnant ( how women become a pregnant)
Pregnancy occurs when a sperm fertilizes an egg after it's released from the ovary during ovulation. The fertilized egg then travels down into the uterus, where implantation occurs. A successful implantation results in pregnancy. On average, a full-term pregnancy lasts 40 weeks.
Some women experience feelings inside their stomachs in the early stages of pregnancy that replicate the sensation of their muscles being pulled and stretched. Sometimes referred to as 'abdominal twinges', these tingles are nothing to worry about.
there is many type of check pregnancy
first at home to check early pregnancy
Walk your fingers up the side of her abdomen ( until you feel the top of her abdomen under the skin. It will feel like a hard ball. You can feel the top by curving your fingers gently into the abdomen. With the woman lying on her back, begin by finding the top of the uterus with your fingers.
Check early pregnancy with strips at home
check by pregnancy with first early morning urine. and many more way to checked your pregnancy .
World globally using are 2 main types of abortion: medical abortion ("abortion pill") – taking medicine to end the pregnancy. surgical abortion – a procedure to remove the pregnancy.
here are two types of abortion methods:
You can have a medical or surgical abortion up to 12 weeks into your pregnancy.
In exceptional circumstances, an abortion can take place after 12 weeks if there:
You may have a choice of abortion methods, although this isn’t always possible.
If you are under 9 weeks pregnant, your GP or doctor will advise you to have a medical abortion.
is a safe and simple procedure used to end a pregnancy. The pregnancy is removed vaginally by an experienced doctor using a suction method.
Surgical abortion involves a minor operation. There are two types of surgical abortion:
The promise of medical abortion to both reduce maternal mortality and morbidity from unsafe abortion and to expand the reproductive rights of women can only be realized if information and reliable
medicines are available to all women, regardless of their location or the restrictions of their legal system. Activist strategies to actualize the full potential of abortion pills are highlighted
The use of medical abortion pills (misoprostol alone or misoprostol in combination with mifepristone), offers a safe and effective method for ending an unwanted pregnancy. Medical abortion has the potential to both reduce maternal mortality and morbidity from unsafe abortion and to expand the reproductive rights of women. However, the promise of these medicines to improve health and enhance rights can only be realized if information and reliable medicines are available to all women,
By creating community level access to medicines, medical abortion gives control to women who need abortion, regardless of the legal constraints of their country. Ironically, in legally restrictive settings medical abortion is currently more under women's control than in settings where medical abortion is used within the official healthcare system. In many countries with legal abortion, abortion pills are subject to strict regulations of supply and provision, with penalties for those that transgress those limits. The current use of medical abortion outside of the medical system in legally restricted settings presents an important lesson about the full potential of this technology. Medical abortion is subversive because it challenges traditional assumptions about service delivery requirements, the definition of a provider and the power dynamics related to providing abortion care. The experiences from settings where self-induced abortions are a lifeline for women provoke reflection about the level of regulation that is needed for medical abortion, and what defines quality of care.
While self-management of medical abortion presents enormous potential for the empowerment of women, the experience of individual women often remains stigmatized. With independent use of abortion medicines, especially in settings with oppressive laws and attitudes, the effects of abortion stigma are multiplied. The helplines support the breaking of this stigma. While individuals who self-manage their own abortion may not always view their actions in a political context, the helplines frame this practice as hands, rejecting systems of law, local medical practice, societal norms, religious norms and sometimes deeply held personal beliefs. In this context, women may recognize that they are committing a political act by refusing to submit to various oppressive systems. This leads to activism around decriminalization, or changing laws and policies. In recent years the notion of provision of information about abortion medicines as a harm reduction strategy has been adopted by some larger non-profit organizations working in reproductive health. While the concept of harm reduction may prove useful for building larger national coalitions, the harm reduction framework stigmatizes self-managed abortion and those that need this type of service. The helplines demonstrate that using abortion pills outside a medical context is not in the same category as “coat hanger abortions” and other unsafe, backstreet methods. Nor is it merely a “less unsafe” last resort when clinic abortions are illegal or unavailable. Self-managed abortion can be a safe and viable option. Putting abortion pills and information into women's hands promotes women's autonomy. Learning the science behind the medicines and being able to support other women is inherently empowering. The helplines translate this self-empowerment into local activism that contributes to the normalization of the abortion experience. They break the taboos around women's sexuality and sexual expression and advocate for de-criminalization of abortion. Additionally, those that become involved in ensuring a supply of reliable medicines to women with unwanted pregnancies, take a powerful position of resistance and political commitment to the right to abortion and self-determination. Local ownership is key to sparking local activism, which links with national and regional advocates. This local ownership creates the potential for systemic change and increases sustainability. Innovative local projects such as hotlines and community programs on dissemination of information medical abortion, working in collaboration and with support from global online
Telephone and some email helplines build on three innovations in health care: medical abortion, m-health/ telemedicine, and task-shifting to new types of providers. The paradigm of surgical abortion required trained clinicians as providers of abortion care and centralized the services in facilities. Conversely, medical abortion invites decentralization, as no facilities are necessary for early medical abortions. Medical abortion allows the reconceptualization of “provider” and the redefinition of “performing” an abortion, as it is the woman herself who can be in control of the process, with support from those who share accurate information, help her to access medicines, and, if needed, support her throughout the abortion process. When a woman herself is empowered with information on how to access the medicines, she is the “provider”, while those who assist her can be seen as her support team. Task-shifting and task-sharing have been recognized in the 2015 World Health Organization's report that highlighted the pivotal role that lay community health workers play when appropriate tasks are shifted and become their responsibility . By empowering community activists to become key providers of safe abortion information, the helplines provide an example of the benefits of such shifting. For example the email helpline of Women Help in dubai.
Misoprostol, sold under the brand name Cytotec among others, is a medication used to prevent and treat stomach ulcers, start labor, cause an abortion, and treat postpartum bleeding due to poor contraction of the uterus. For abortions it is used by itself and with mifepristone or methotrexate
Misoprostol is a synthetic prostaglandin E1 analogue that is used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, medical management of miscarriage, induction of labor, cervical ripening before surgical procedures, and the treatment of postpartum hemorrhage. Due to its wide-ranging applications in reproductive health, misoprostol is on the World Health Organization Model List of Essential Medicines. This article briefly reviews the varied uses of misoprostol in obstetrics and gynecology.
he FDA approved medication abortion using 600 mg of oral mifepristone, a progesterone antagonist, with 400 µg of oral misoprostol 48 hours later for pregnancies up to 49 days of gestation. However, there is excellent evidence of efficacy up to 63 days of gestation using the regimens of 200 mg of mifepristone orally followed by home administration of either 800 µg of buccal misoprostol in 24 to 36 hours or 800 µg of vaginal misoprostol in 6 to 48 hours.22,23 Women then return 4 to 14 days later for a clinical evaluation to document complete abortion. Success rates for these regimens range from 95% to 98%, with failure due to ongoing pregnancy in approximately 1%. In the United States, most women undergo ultrasound for pregnancy dating and confirmation of complete abortion. However, serial serum β-human chorionic gonadotropin (βhCG) levels can also be used to confirm complete abortion.
Candidates for medication abortion must be able to adhere to the treatment regimen as well as have access to a telephone and transportation to a medical facility in case of emergency. Multiple gestation is not a contraindication to medication abortion provided that the pregnancy is no more than 49 to 63 days, depending on the regimen being used. Contraindications to mifepristone medication abortion include hemorrhagic disorder; concurrent anticoagulant therapy; inherited porphyria's; chronic adrenal failure; concurrent long-term systemic corticosteroid use; confirmed or suspected ectopic or molar pregnancy; allergy to mifepristone, misoprostol, or other prostaglandin; and unwillingness to undergo a vacuum aspiration if needed. If the woman has an intrauterine device in place, it must be removed before treatment. Women with serious systemic illnesses (eg, severe cardiac, renal, or liver disease or severe anemia) should be evaluated individually to determine which method of abortion is safest. Rhesus (Rh)-negative women typically receive Rh immune globulin on the day of mifepristone administration.
Medication abortion necessarily involves heavy bleeding and cramping as the pregnancy is expelled. Other transient side effects from misoprostol include nausea, vomiting, diarrhea, fever, and chills. At the follow-up visit, ongoing pregnancies are most commonly treated with suction curettage because of the risk of congenital anomalies. Women with persistent nonviable pregnancies may opt for expectant management, a repeat dose of misoprostol, or suction curettage. Mifepristone medication abortion is safe with an estimated complication rate of 2.2 per 1000 women. The most frequent complications are heavy bleeding requiring curettage and/or transfusion and infection. The estimated mortality rate for mifepristone abortion is 1 per 100,000 women, most commonly due to fatal sepsis Where mifepristone is not available, medication abortion can be accomplished with methotrexate and miso The objective was to learn what complications some women experienced in Madagascar following use of misoprostol for abortion and what treatment they received post misoprostol use.
This was a qualitative study in 2015–2016 among women who had experienced complications after use of misoprostol, with or without additional methods, for abortion; what information they received before use; what dosage and regimens they used; what complications they experienced; and what treatment they received postuse. We initially conducted in-depth, semistructured interviews with 60 women who had undergone an abortion that resulted in complications. The results presented here are based on interviews with the subset of 19 women who had used misoprostol.
he 19 women were aged 16–40, with an average age of 21–26 at interview and average age of 18–21 at abortion. To obtain an abortion, they sought advice from partners, friends, family members, and/or traditional practitioners and health care providers. Misoprostol was easily accessible through the formal and informal sectors, but the dosages and regimens the women used on the advice of others were extremely variable, did not match WHO guidelines and were apparently ineffective, resulting in failed abortion, incomplete abortion, heavy bleeding/hemorrhage, strong pain and/or infection.
Health care providers who provide abortion care and treatment of abortion complications need training in correct misoprostol use and treatment of complications. Women and pharmacy workers also need this information. Law and policy reforms are needed to allow training and provision of safe services. Further research is needed on the extent and impact of incorrect misoprostol administration.
Most of the women said they were only able to give an estimate of how many weeks pregnant they were at the time of misoprostol use. A small number had used misoprostol as soon as they noticed they had delayed menses. The estimates of the others varied from 2 to 2.5 months pregnant, to about 3 months pregnant, about 4 months pregnant and 5 months pregnant, but almost all were below 12 weeks.
Their use of misoprostol was also haphazard. Ten of the women had used misoprostol in varying dosages following a consultation with a midwife or doctor; seven had self-administered the pills in amounts they decided upon themselves; and two had used the pills following a consultation with a traditional birth attendant. Most of the seven women who self-medicated took the pills orally. They took between 8 and 20 tablets, spaced out at different intervals — half an hour, an hour, 2 h or 12 h. Only two women who self-administered the misoprostol used vaginal administration. Of those two, one woman used 10 Cytotec pills in total, administering two tablets vaginally every 3 h. The other inserted one misoprostol tablet vaginally and took nine tablets orally every 30 min.
When the misoprostol was prescribed by a health care provider, the administration and number of tablets were just as varied as with self-use. Some prescribed oral use only (for example, taking anything from 7 to 12 tablets one by one at hourly intervals). One midwife in a health center prescribed four pills, one every evening. Others prescribed combined vaginal and oral administration — for example, inserting between one and four tablets vaginally and then taking between 2 and 10 tablets orally, one by one, at hourly intervals. One traditional birth attendant prescribed one tablet of misoprostol every 12 h for 2 days to one woman. Some health professionals also used another method along with the misoprostol (for example, a probe or an oxytocin injection), or prescribed misoprostol preceding a curettage. One woman described some kind of simultaneous surgical intervention:
“The doctor made me lie down on a bed. First, he introduced I don't know, a round thing. It seemed to me that it turned like a spring does, when he inserted it in the passage. Afterwards, he introduced the probe, and he left the probe in. And he said, ‘You're going home, but you're going to come back here tomorrow.’ He gave me Cytotec, Cytotec, small tablets, he gave me some. He said: ‘Here are the Cytotec tablets, when it's seven o'clock sharp, you'll swallow two and you'll introduce two in the vagina. When it's eight o'clock, you'll do the same thing. When it's nine o'clock, you'll do the same. Then at ten o'clock, it's the last time.’”
The clinical safety, efficacy and acceptability of mifepristone and misoprostol in the Indian context have been well studied, but little is known about how they are being used, who is using them, how women access them or how providers, chemists, women and their partners perceive medical abortion. This paper reports on part of a study on these issues, a survey of 209 chemists, in the Indian states of Bihar and Jharkhand in 2004. It found that only 34% of the interviewed chemists stocked mifepristone and misoprostol, sales volumes were low and there was more demand for cheaper, often ineffective preparations for abortion. Men were more likely to buy abortifacient drugs than women. Chemists knew mifepristone and misoprostol were prescription drugs but less about dosage and side effects. Most sales appeared to be prescription driven, but some over the-counter sales did occur, especially when ability to pay seemed high or the chemist knew the customer. Chemists need accurate information on the drugs they sell as abortifacients, encouragement to promote pregnancy tests, training in encouraging women to see a provider prior to purchase, and visual and written material to hand out. Better adherence to existing regulations for all prescription drugs is important, but the best course is to increase the availability of low-cost, safe abortion services at primary care level
was licensed for use in India in 2002, following which four pharmaceutical companies began marketing the drug. This had risen to seven companies by mid-2005. Misoprostol has been available as a medication for gastric ulcer treatment, and as elsewhere its abortifacient use is off-label. In-country consensus protocols and guidelines for appropriate use of mifepristone–misoprostol for medical abortion in early pregnancy were developed in 2004 by a National Consortium, consisting of national and international experts,1,2 but at this writing neither drug had been introduced into public sector health services. Both mifepristone and misoprostol can be sold through chemist outlets but only on prescription (as Schedule H drugs, Drug and Cosmetics Rule
Lastly, it is important to note that the women expressed astonishment in the interviews that they had experienced method failure and complications with misoprostol, which demonstrates not only how much confidence they had in the efficacy of misoprostol to cause an abortion but also how little they and the health care providers they consulted actually knew about how to use misoprostol safely and effectively. This is perhaps not surprising given the failure of the state or the health system to take any responsibility for abortion. Yet the women painted a picture of the health care professionals who advised and treated them as showing great willingness to help them when they were in trouble, both before their attempted abortion and when they consulted them with complications. s,
Medical abortion with mifepristone and misoprostol is a well-established and acceptable method 1. It has become the most common method in Norway since it was introduced in 1998 2, and was in 80.5% of all medical abortions in 2012 3. Norway has abortion on request, completely free of charge and easily accessible at every gynecology ward up to 12 weeks of gestation 4. The population (5 million) is distributed over a large area, with many people living in rural areas far from the nearest hospital. Increasing access to safe and acceptable treatment close to or at home would be an advantage.
Home administration of misoprostol for up to 9 weeks’ gestation has been available in the USA since 2000 5. In Europe, on the other hand, except Scandinavia, a more restrictive attitude towards home administration of medical abortion has prevailed. Home administration has either not been allowed or has been restricted to a lower gestational age, most commonly up to 49 days 6.
Except for a Swedish study that found home administration of misoprostol just as acceptable at 50–63 days’ gestation as at <50 days’ gestation 7, very few studies from Europe have reported on home treatment beyond 56 days’ gestation. Several studies, including Swedish studies, have limitations as to the travel time from provider for those who would like to administer misoprostol at home 7–9. A 1-h travel limit is not uncommon; however, none of these studies has looked at the importance of proximity to provider 7–9. Although the majority of women in Europe live close to a health facility, not all women do so, and internationally many women live in less urbanized settings with limited access to health facilities.
Medical abortion with home administration of misoprostol up to 63 days’ gestation and no travel distance limitation was introduced at Hauk eland University Hospital, Bergen, Norway, in 2006 with the objective to increase women’s choice. It rapidly became the preferred procedure for women at this gestational age. Home administration is here defined as not conducted within the hospital.
The aim of this study was to evaluate the consequences of implementing home administration of misoprostol. This method was introduced to increase and facilitate women’s access to medical abortion regardless of residence and travel distance from hospital
Dubai is state of one of the Muslim country where is the abortion is too difficult married couple and un married couple who was living in dubai abu dhabi Sharjah ajman Fujairah ras al khaimah .
we solve your problem to help out to abort you your unwanted pregnancy .100% guarantee and give you original abortion pills in uae ( dubai )searching me on google with the title """" abortion pills available in dubai"""
also contact me at my website on google
Copyright © 2013 Pills in oman- All Rights Reserved.